# Trade Mark Journal No.2026/017 24 April 2026

## UK00004369647 7 April 2026 (5,42)

Class 5
  Pharmaceutical preparations for the treatment of and prevention of ophthalmic disorders; pharmaceutical preparation for the treatment of and prevention of metabolic syndromes; pharmaceutical preparations for the treatment of cancer.
Class 42
  Pharmaceutical research and development services; development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of ophthalmic disorders, metabolic syndromes, and cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.

Belite Bio, Inc

Representative: Kilburn & Strode LLP